China Meheco Group Co., Ltd. (SHA:600056)
9.56
+0.03 (0.31%)
Jul 31, 2026, 3:00 PM CST
China Meheco Group Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 35,023 | 35,362 | 35,243 | 38,824 | 37,593 | 36,234 |
Revenue Growth | 0.08% | 0.34% | -9.22% | 3.28% | 3.75% | -7.83% |
Gross Profit Gross Profit Growth | 3,639 | 3,671 | 3,721 | 4,354 | 4,638 | 4,692 |
Operating Income Operating Income Growth | 1,305 | 1,324 | 1,261 | 1,292 | 1,417 | 1,375 |
Net Income Net Income Growth | 482.86 | 473.23 | 582.58 | 1,048 | 735.6 | 647.06 |
Earnings Per Share EPS Growth | 0.32 | 0.32 | 0.39 | 0.70 | 0.49 | 0.43 |
EPS Growth | -20.80% | -18.77% | -44.41% | 42.46% | 13.69% | -50.62% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Big Health and E-commerce Big Health and E-commerce Growth | 1,249 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 2,540 |
Offset of Business Segment Offset of Business Segment Growth | -136.3 |
Pharmaceutical Commercial Pharmaceutical Commercial Growth | 26,208 |
International Trade International Trade Growth | 5,501 |
Total Total Growth | 35,362 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,532 | 4,211 | 4,485 | 3,867 | 4,290 | 2,829 |
Total Debt Total Debt Growth | 5,537 | 5,260 | 6,447 | 5,620 | 5,380 | 4,708 |
Net Cash (Debt) Net Cash Growth | -3,005 | -1,048 | -1,962 | -1,753 | -1,090 | -1,880 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.01 | -0.70 | -1.31 | -1.17 | -0.73 | -1.26 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,477 | 1,426 | 1,012 | 859.08 | 1,646 | 148.42 |
Capital Expenditures CapEx Growth | -328.55 | -333.11 | -358.68 | -362.55 | -228.96 | -286.15 |
Free Cash Flow Free Cash Flow Growth | 1,149 | 1,093 | 653.12 | 496.52 | 1,417 | -137.73 |
Free Cash Flow Growth | 177.90% | 67.31% | 31.54% | -64.96% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 10.39% | 10.38% | 10.56% | 11.21% | 12.34% | 12.95% |
Operating Margin | 3.73% | 3.74% | 3.58% | 3.33% | 3.77% | 3.80% |
Pretax Margin | 2.86% | 2.83% | 2.86% | 4.23% | 3.18% | 2.59% |
Profit Margin | 1.38% | 1.34% | 1.65% | 2.70% | 1.96% | 1.79% |
FCF Margin | 3.28% | 3.09% | 1.85% | 1.28% | 3.77% | -0.38% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.095 | 0.095 | 0.107 | 0.210 | 0.148 | 0.130 |
Dividend Per Share Growth | 10.81% | -11.62% | -48.91% | 42.45% | 13.68% | -50.63% |
Dividend Yield | 0.99% | 0.93% | 0.98% | 1.96% | 0.90% | 1.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 29.61 | 32.65 | 28.50 | 15.94 | 35.04 | 19.50 |
Forward PE | - | 10.94 | 10.94 | 10.94 | 10.94 | 10.94 |
P/FCF Ratio | 12.45 | 14.14 | 25.42 | 33.65 | 18.19 | - |
PS Ratio | 0.41 | 0.44 | 0.47 | 0.43 | 0.69 | 0.35 |